These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 559690)

  • 41. [Use of bromocriptine to induce ovulation in the galactorrhea-amenorrhea syndrome [].
    Hernández Ayup S; Muñoz M; González R; Galache P; Guitrón A; Pancardo RM; Forsbach G
    Rev Invest Clin; 1982; 34(2):121-3. PubMed ID: 7123023
    [No Abstract]   [Full Text] [Related]  

  • 42. Editorial: Galactorrhea-amenorrhea, brom-ergocryptine, and the dopamine receptor.
    Boyd AE; Reighlin S
    N Engl J Med; 1975 Aug; 293(9):451-2. PubMed ID: 1171365
    [No Abstract]   [Full Text] [Related]  

  • 43. [Treatment of amenorrhea-galactorrhea with bromo-ergocryptine. Apropos of 12 cases].
    Hartemann P; Leclere J; Groussin M; Valdenaire JC; Maureira JJ; Belleville F; Nabet P
    J Gynecol Obstet Biol Reprod (Paris); 1977 Jun; 6(4):537-46. PubMed ID: 915214
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine.
    Lamberts SW; Seldenrath HJ; Kwa HG; Birkenhäger JC
    J Clin Endocrinol Metab; 1977 Jan; 44(1):180-4. PubMed ID: 576229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of CB-154 (2 Br-a-ergocryptine) on serum follicle stimulating hormone, luteinzing hormone and prolactin in women with the amenorrhoea-galactorrhoea syndrome.
    Seki K; Seki M; Okumura T
    Acta Endocrinol (Copenh); 1975 May; 79(1):25-33. PubMed ID: 1173307
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bromocriptine in the treatment of hyperolactinemic amenorrhea.
    Badano AR; Miechi HR; Mirkin A; Arcángeli OA; Aparicio NJ; Rodríguez A; Oliva A; Turner D; Figueroa Casas PR
    Fertil Steril; 1979 Feb; 31(2):124-9. PubMed ID: 570131
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The treatment with 2-brom-alfa ergocriptine in the syndrome amenorrhea-galactorrhea.
    Sirbu P; Cioltei A; Simionescu L; Dumbravescu A; Sedan E; Titiriga L; Mîtulescu V
    Acta Eur Fertil; 1979 Dec; 10(4):177. PubMed ID: 552769
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Intermittent administration of bromocriptine in the treatment of amenorrhea-galactorrhea syndrome].
    Hartemann P; Leclere J; Groussin M; Mizrahi R
    Nouv Presse Med; 1977 Oct; 6(34):3111. PubMed ID: 562510
    [No Abstract]   [Full Text] [Related]  

  • 49. [Evolution of 15 pregnancies induced with bromocriptine therapy in patients with amenorrhea-galactorrhea].
    Campagnoli C; Belforte L; Bruno M; Fessia L; Pinna N; Massara F
    Minerva Ginecol; 1980 May; 32(5):400-4. PubMed ID: 7393487
    [No Abstract]   [Full Text] [Related]  

  • 50. Normal pregnancies after treatment of hyperprolactinemia with bromoergocryptine, despite suspected pituitary tumors.
    Mornex R; Orgiazzi J; Hugues B; Gagnaire JC; Claustrat B
    J Clin Endocrinol Metab; 1978 Aug; 47(2):290-5. PubMed ID: 400717
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Successful treatment of galactorrhea, anemorrhea and infertility with a new ergot alkaloid (2-Br-alpha-ergocryptine)].
    Schellekens LA; Roland R; Lequin RM
    Ned Tijdschr Geneeskd; 1975 Apr; 119(14):541-7. PubMed ID: 1170514
    [No Abstract]   [Full Text] [Related]  

  • 52. Hyperprolactinaemic amenorrhoea in Hong Kong.
    Tang LC; Sung ML; Ma HK
    Aust N Z J Obstet Gynaecol; 1983 Aug; 23(3):165-9. PubMed ID: 6580885
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Remote results of treatment of galactorrhea-amenorrhea syndromes and functional sterility with increased prolactin concentration by means of bromocriptine (Parlodel-Sandoz)].
    Tomala J; Dudkiewicz J; Blecharz AJ
    Ginekol Pol; 1980 Mar; 51(3):255-8. PubMed ID: 6771191
    [No Abstract]   [Full Text] [Related]  

  • 54. Bromocriptine. Clinical experience in the induction of pregnancy in amenorrhea-galactorrhea syndrome.
    Zárate A; Canales ES; Forsbach G; Fernández-Lazala R
    Obstet Gynecol; 1978 Oct; 52(4):442-4. PubMed ID: 714326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Galactorrhea-amenorrhea syndromes: etiology and treatment.
    Spark RF; Pallotta J; Naftolin F; Clemens R
    Ann Intern Med; 1976 May; 84(5):532-7. PubMed ID: 945033
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [2-Br-alpha-ergocryptine in the treatment of amenorrhea-galactorrhea syndromes and in inhibition of puerperal lactation. Effect on secretion of prolactin and pituitary gonadotropin].
    Cagnazzo G; Schonauer S; Lodico G; Lotti G; Delitala G; Masala A
    Minerva Ginecol; 1976 Oct; 28(10):761-70. PubMed ID: 1036769
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of prolactin in human milk composition and serum lipids studied during suppression of galactorrhea with bromocriptine.
    Kandan S; Gopalakrishnan V; Govindarajulu P; Indira R; Malathi T
    Horm Res; 1983; 17(2):93-102. PubMed ID: 6682397
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyproheptadine in the management of the galactorrhea-amenorrhea syndrome.
    Wortsman J; Soler NG; Hirschowitz J
    Ann Intern Med; 1979 Jun; 90(6):923-5. PubMed ID: 571691
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Results of bromocriptine treatment of women with functional amenorrhea-galactorrhea syndrome].
    Baranowska B; Stopińska-Głuszek U; Jeske W
    Endokrynol Pol; 1984; 35(4):219-29. PubMed ID: 6510365
    [No Abstract]   [Full Text] [Related]  

  • 60. [Treatment of the galactorrhea and amenorrhea syndrome associated with acromegaly using 2-bromine-alpha-ergocryptine].
    Durić DS; Dordević PB; Mićić JV; Popović SS
    Srp Arh Celok Lek; 1977 Feb; 105(2):179-89. PubMed ID: 562001
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.